Oppenheimer Initiates Coverage On Precision BioSciences with Outperform Rating, Announces Price Target of $20
Benzinga Newsdesk 4 months ago
NewsPrice TargetInitiationAnalyst Ratings
Oppenheimer analyst Joseph Thome initiates coverage on Precision BioSciences (NASDAQ:DTIL) with a Outperform rating and announces Price Target of $20.
Oppenheimer analyst Joseph Thome initiates coverage on Precision BioSciences (NASDAQ:DTIL) with a Outperform rating and announces Price Target of $20.